Mode
Text Size
Log in / Sign up
N/A N=30 Supportive Care

Self-System Therapy for Older Adults With Lung Cancer

Lung Cancer Stage III · Lung Cancer Stage IV

Enrolled (actual)
30
Serious AEs
10.0%
Results posted
Aug 2022
Primary outcome: Primary: Number of Patients That Complete SST Treatment Sessions — 23 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Self-System Therapy for Older Adults with Advanced Lung Cancer (SST-LC) (Behavioral)
Age
Older Adult · 65+ yrs
Sex
All
Sponsor
Duke University
Primary completion
May 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Patients That Complete SST Treatment Sessions
23
PRIMARY
Patient Satisfaction With Treatment
30.78
SECONDARY
General Distress as Measured by the CORE-10 (Clinical Outcomes in Routine Evaluation 10) at Baseline
14.55
SECONDARY
General Distress as Measured by the CORE-10 at 12 Weeks
12.67
SECONDARY
General Distress as Measured by the CORE-10 at 1-month Follow-up
12.30
SECONDARY
Depression as Measured by the Beck Depression Inventory (BDI-II) at Baseline
9.41
SECONDARY
Depression as Measured by the Beck Depression Inventory (BDI-II) at 12 Weeks
6.17
SECONDARY
Depression as Measured by the Beck Depression Inventory (BDI-II) at 1-month Follow-up
6.13
SECONDARY
Functioning as Measured by the Functional Assessment of Cancer Therapy- Lung (FACT-L)
102.22; 109.12; 101.47
SECONDARY
Number of Participants With Participant-reported Mobility Indices Available
30; 23; 21
SECONDARY
Number of Participants With Physical Activity Scale for the Elderly (PASE) Scores Available
30; 23; 21
SECONDARY
Number of Participants With Computerized Selves Questionnaire (CSQ) Responses Available at Baseline
30
SECONDARY
Number of Participants With Regulatory Focus Questionnaire (RFQ) Responses Available at Baseline
30
SECONDARY
Treatment Session Fidelity as Measured by Number of Participants Who Were Taught All Skills.
24

Summary

The purpose of this study to use Self-system therapy (SST), to treat depression and lung-cancer-related distress in older adults (65 years and older).

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 65 years
  • English-speaking
  • The patient has a diagnosis of late-stage (III-IV) lung cancer and is living at her/his home.

Exclusion Criteria

  • Unable to provide informed consent
  • Visual or hearing impairments that preclude participation
  • Serious mental illness
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04057196). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search